TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09 2024 - 4:05PM
TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage
medical technology company focused on providing innovative
soft-tissue reconstruction solutions, today announced that the
Compensation Committee of the Board of Directors of TELA Bio
approved inducement grants of restricted stock units covering
16,000 shares of its common stock to nine newly-hired employees,
with a grant date of August 6, 2024 (the "Grant Date"). The
restricted stock units were granted pursuant to the Nasdaq Rule
5635(c)(4) inducement grant exception as a component of each
individual's employment compensation and were granted as an
inducement material to his or her acceptance of employment with
TELA Bio.
The restricted stock units will vest in equal annual
installments over four years, subject to each individual's
continued service with TELA Bio through the applicable vesting
dates.
About TELA
Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical
technology company focused on providing innovative technologies
that optimize clinical outcomes by prioritizing the preservation
and restoration of the patient's own anatomy. The Company is
committed to providing surgeons with advanced, economically
effective soft-tissue reconstruction solutions that leverage the
patient's natural healing response while minimizing long-term
exposure to permanent synthetic materials. For more information,
visit www.telabio.com.
Caution Regarding
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of The Private Securities Litigation Reform Act of
1995. Words such as "may," "might," "will," "should," "believe,"
"expect," "anticipate," "estimate," "continue," "predict,"
"forecast," "project," "plan," "intend" or similar expressions, or
statements regarding intent, belief, or current expectations are
forward-looking statements and reflect the current beliefs of TELA
Bio's management. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and
other factors that could cause actual results and events to differ
materially and adversely from those indicated by such
forward-looking statements. These risks and uncertainties are
described more fully in the "Risk Factors" section and elsewhere in
our filings with the Securities and Exchange Commission and
available at www.sec.gov, including in our Annual Report on Form
10-K and Quarterly Reports on Form 10-Q. Any forward-looking
statements that we make in this announcement speak only as of the
date of this press release, and TELA Bio assumes no obligation to
update forward-looking statements whether as a result of new
information, future events or otherwise after the date of this
press release, except as required under applicable law.
Investor Contact Greg
Chodaczek 332-895-3230ir@telabio.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Sep 2024 to Oct 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Oct 2023 to Oct 2024